Literature DB >> 3728640

Cone adaptation in age-related maculopathy.

B Brown, C Tobin, N Roche, A Wolanowski.   

Abstract

Cone adaptation was measured in patients with age-related maculopathy (ARM) and age-matched controls. A red stimulus was used to selectively bias responses toward cone function and adaptation was measured 5, 10, 20, and 40 degrees eccentric to fixation. The ARM patients' thresholds were elevated by 1 log unit at 5 and 10 degrees, with the threshold difference reducing to 0.5 log units at 40 degrees. Curves of the form log (threshold luminance) = ae-bt + c (where t is time and a, b, and c are constants) were fitted to each adaptation curve; a procedure involving differentiation of the above equation was used to estimate the constant parameters. Time constants of cone recovery (1/b) were derived for each fitted curve. No significant difference was found between the time constants of the two test groups. Our data suggest that cone adaptation is significantly affected in patients with ARM, with raised cone thresholds occurring for areas well into the peripheral retina. We suggest that the effect is mediated by a reduction in the number of functional cones, which elevates the final cone thresholds without altering the adaptation time constant. Our findings imply that age-related "maculopathy" may not be confined to the macular area, and that early signs of the degeneration may be present in the peripheral retina even when central acuity is normal.

Entities:  

Mesh:

Year:  1986        PMID: 3728640     DOI: 10.1097/00006324-198606000-00009

Source DB:  PubMed          Journal:  Am J Optom Physiol Opt        ISSN: 0093-7002


  8 in total

1.  Effects of long-term administration of 9-cis-retinyl acetate on visual function in mice.

Authors:  Tadao Maeda; Akiko Maeda; Patrick Leahy; David A Saperstein; Krzysztof Palczewski
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-15       Impact factor: 4.799

2.  Effect of age related macular degeneration on the Eger macular stressometer photostress recovery time.

Authors:  J S Wolffsohn; S J Anderson; J Mitchell; A Woodcock; M Rubinstein; T Ffytche; A Browning; K Willbond; W M Amoaku; C Bradley
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

3.  Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration.

Authors:  Janet S Sunness; Gary S Rubin; Aimee Broman; Carol A Applegate; Neil M Bressler; Barbara S Hawkins
Journal:  Ophthalmology       Date:  2008-05-16       Impact factor: 12.079

4.  Alternative complement pathway deficiency ameliorates chronic smoke-induced functional and morphological ocular injury.

Authors:  Alex Woodell; Beth Coughlin; Kannan Kunchithapautham; Sarah Casey; Tucker Williamson; W Drew Ferrell; Carl Atkinson; Bryan W Jones; Bärbel Rohrer
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

5.  Quantitative analysis of cone photoreceptor distribution and its relationship with axial length, age, and early age-related macular degeneration.

Authors:  Ryo Obata; Yasuo Yanagi
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

6.  Photoreceptor alteration in intermediate age-related macular degeneration.

Authors:  Enrico Borrelli; Riccardo Sacconi; Biancamaria Zuccaro; Michele Cavalleri; Alessandro Bordato; Ilaria Zucchiatti; Lea Querques; Francesco Bandello; Giuseppe Querques
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

7.  A short-duration dark adaptation protocol for assessment of age-related maculopathy.

Authors:  Gregory R Jackson; John G Edwards
Journal:  J Ocul Biol Dis Infor       Date:  2008-05-06

8.  Cone photoreceptor macular function and recovery after photostress in early non-exudative age-related macular degeneration.

Authors:  John D Rodriguez; Keith Lane; David A Hollander; Aron Shapiro; Sunita Saigal; Andrew J Hertsenberg; Garrick Wallstrom; Divya Narayanan; Endri Angjeli; Mark B Abelson
Journal:  Clin Ophthalmol       Date:  2018-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.